Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-04
2006-07-04
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S259000
Reexamination Certificate
active
07071193
ABSTRACT:
Pteridine compounds of formula (I)processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in the treatment of inflammatory diseases such as psoriasis, rheumatoid arthritis, diseases in which angiogenesis is assocated with raised CXCR2 chemokine levels (diabetic retinopathy) and COPD. The compounds are ligands for chemokine receptors and medical indications mentioned in the description include: diseases of the respiratory tract (COPDD, asthma, bronchitis, rhinitis, fibroid lung, pneumonia, etc.), diseases of the bones and joints (arthritis, etc.), skin-diseases (psoriasis, etc), diseases of the gastrointestinal tract, diseases in other tissues and systemic disease (multipe sclerosis, atherosclerosis, AIDS, type 1 diabetes, leprosy, sepsis, etc.), allograft rejection, cancers, cystic fibrosis, stroke, burn wounds, skin ulcers, reproductive disease and more.
REFERENCES:
patent: 2924472 (1960-02-01), Bush
patent: 3182062 (1965-05-01), Pachter et al.
patent: 3318900 (1967-05-01), Janssen
patent: 3445120 (1969-05-01), Barr
patent: 4061459 (1977-12-01), Parmann
patent: 4126689 (1978-11-01), Sanczuk et al.
patent: 4188040 (1980-02-01), Wolf et al.
patent: 4213619 (1980-07-01), Arlt et al.
patent: 4234199 (1980-11-01), Moncaster et al.
patent: 4278677 (1981-07-01), Nedelec et al.
patent: 4410528 (1983-10-01), Teranishi et al.
patent: 4483544 (1984-11-01), Faerber et al.
patent: 4641858 (1987-02-01), Roux
patent: 5064207 (1991-11-01), Bengtsson
patent: 5169161 (1992-12-01), Jones
patent: 5297824 (1994-03-01), Imhof et al.
patent: 5521197 (1996-05-01), Audia
patent: 5599028 (1997-02-01), Neumann et al.
patent: 5826887 (1998-10-01), Neumann et al.
patent: 5988695 (1999-11-01), Corbett, Jr.
patent: 6142484 (2000-11-01), Valls, Jr.
patent: 6172067 (2001-01-01), Ito et al.
patent: 6248755 (2001-06-01), Chapman et al.
patent: 6329381 (2001-12-01), Kurimoto et al.
patent: 6407121 (2002-06-01), Nagamine et al.
patent: 6432981 (2002-08-01), Finke et al.
patent: 6790854 (2004-09-01), Tsushima et al.
patent: 6958343 (2005-10-01), Bonnert et al.
patent: 6958344 (2005-10-01), Bonnert et al.
patent: 2331223 (1974-01-01), None
patent: 41 19 767 (1992-12-01), None
patent: 0 293 078 (1988-11-01), None
patent: 0 447 324 (1991-09-01), None
patent: 0 778 277 (1997-06-01), None
patent: 1 069 124 (2001-01-01), None
patent: 1 122 257 (2001-08-01), None
patent: 1009477 (1965-11-01), None
patent: 2359079 (2001-08-01), None
patent: 51-88994 (1976-08-01), None
patent: WO 97/22596 (1997-06-01), None
patent: WO 97/30035 (1997-08-01), None
patent: WO 97/32856 (1997-09-01), None
patent: WO 97/40035 (1997-10-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 98/25617 (1998-06-01), None
patent: WO 99/02166 (1999-01-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/17773 (1999-04-01), None
patent: WO 99/36421 (1999-07-01), None
patent: WO 99/51608 (1999-10-01), None
patent: WO 00/08013 (2000-02-01), None
patent: WO 00/09511 (2000-02-01), None
patent: WO 00/38680 (2000-07-01), None
patent: WO 00/39129 (2000-07-01), None
patent: WO 00/40529 (2000-07-01), None
patent: WO 00/41669 (2000-07-01), None
patent: WO 00/45800 (2000-08-01), None
patent: WO 00/59502 (2000-10-01), None
patent: WO 00/76514 (2000-12-01), None
patent: WO 01/19825 (2001-03-01), None
patent: WO 01/25200 (2001-04-01), None
patent: WO 01/25242 (2001-04-01), None
patent: WO 01/58902 (2001-08-01), None
patent: WO 01/58906 (2001-08-01), None
patent: WO 01/58907 (2001-08-01), None
patent: WO 01/62758 (2001-08-01), None
patent: WO 01/92224 (2001-12-01), None
patent: WO 02/04434 (2002-01-01), None
patent: WO 02/08213 (2002-01-01), None
patent: WO 02/083693 (2002-10-01), None
patent: WO 03/024966 (2003-03-01), None
patent: WO 04/026835 (2004-04-01), None
patent: WO 04/026880 (2004-04-01), None
Pachter and Nemeth, “Pteridines. I. Synthesis of Some 6-alkyl-7-amino-pteridines from Ntirosopyrimidines” Journal of Organic Chemistry, vol. 28, pp. 1187-1191 (1963).
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Spickett and Timmis, “The Synthesis of Compounds with Potential Antic-folic Acid Activity. Part I. 7-Amino- and 7-Hydroxy-pteridines” Journal of the Chemical Society, pp. 2887-2895 (1954).
Weinstock et al, “Pteridines. XII. Structure-Activity Relationships of Some Pteridine Diuretics” Journal of Medicinal Chemistry, vol. 11(3), pp. 573-579 (1968).
Hagmann et al, “Section IV: Immunology, Endocrinology and Metabolic Diseases” Annual Reports in Medicinal Chemistry, vol. 38, pp. 191-200 (2000).
Joseph Weinstock, et al., “Structure-Activity Relationships of Some Pteridine Diuretics,” J. Med. Chem, vol. 11, No. 3, pp. 573-579 (Jan. 6, 1968).
Chemcasts, Accession No. 2001:1442861, “4, 7-Pteridinediamine, 9-phenyl-2-[(phenylmethyl)thio]-,” CAS Registry 343347-55-7 (Jul. 1, 2001).
CAPLUS, Accession No. 2000:76301, Document No. 132:98128, “Antiinflammatory and analgesic capsules containing betamethasone, vitamin B6, dihydrochlorothiazide and triamterene”. (2000).
Ahmed et al., “Novel synthesis of 1-aryl-9-alkyl-2,3,3a,4,9,9a-hexahydro-1H-pyrrolo[2,3-b]quinoxalines by lithium aluminum hydride reduction of N-phenyl-1-benzimidazolylsuccinimides”, CAPLUS 79:92106 (1973).
Baly et al., “Biological Assays for C-X-C Chemokines”,Methods in Enzymology287:69-88 (1997).
Chemical Abstracts, vol. 54, No. 10, May 1960, Abstract No. 9933f, C. Wayne Noell and Roland K. Robins, “Potential Purine Antagonists XVII. Synthesis of 2-methyl and 2-methylthio-6, 8-disubstituted purines”, see Formula III when R-SMe, R1=C1, R2=OH.
Cohen et al., “Cytokine Function: A study in biologic diversity”, CAPLUS 125:31527 (1996).
Cowley et al., “Preparation of 1-(3-phenyloxypropyl)piperdine derivatives as opioid receptor ligands”, CAPLUS 138:39189 (2002).
Finke et al., “Preparation of piperidinylmethylcyclopentanes as modulators of CCR-5 and/or CCR-3 chemokine receptors”, CAPLUS 134:56576 (2000) CAS Listing, 77 answers.
Fukuda et al., “Preparation of benzotriazole derivatives as cardiovascular agents and antipsychotics”, CAPLUS 123:340149 (1995).
Gewald et al., “New Synthesis of Substituted 4-Amino-quinazolines and Their Heteroanaloga”,J. prakt. Chem.338:206-213 (1996).
Grant, “University of Minnesota—Twin Cities Campus College of Pharrmacy, Annual Report”, [online] 1999, [retrieve on Feb. 13, 2003]. Retrieved from the internet, http://www.msi.umn.edu/general/Reports/ar99/departments/pharmacy.html.
Kiriasis et al., “Synthesis and Properties of New Pteridine Nucleosides”,Dev. Biochem.4:49-53 (1978).
Lee et al., “Characterization of Two High Affinity Human Interleukin-8 Receptors”,J. Biol. Chem.267:16283-16287 (1992).
McNaught et al., “IUPAC Compendium of Chemical Terminology, 2ndEd” (1997).
Merritt et al., “Use of fluo-3 to measure cytosolic Ca2+in platelets and neutrophils: Loading cells with a dye, calibration of traces, measurements ini the presence of plasma, and buffering of cytosolic Ca2+”,Biochem. J.269:513-519 (1990).
Ott et al., “4-amino-7, 8-dihydro-2-(methylmercapto(-8-β, -D-ribofuranosylpteridin-7-One. Modified Fusion Reaction with Trimethylsilylated Pteridine Derivatives”,Nucl. Acid. Chem.2:735-739 (1978).
Ott et al., “Zur Synthese des 4-Amino-7-oxo-7, 8-dihydropteridin-N-8-β-D-ribofuranosids—ein strukturanaloges Nucleosid des Adenosins”,Chem.Ber.107:339-361 (1974).
Patent Abstracts of Japan, abstract of JP-5-202047 A (Chugai Pharmaceut. Co. Ltd.) Aug. 10, 1993.
Sato et al., “Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-flurophenyl)-1-butanones with p
Bonnert Roger
Walters Iain
AstraZeneca AB
Fish & Richardson P.C.
Tucker Zachary C.
Wilson James O.
LandOfFree
7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3593095